COPENHAGEN, Denmark, April 4, 2011 (GLOBE NEWSWIRE) -- Exiqon A/S (Copenhagen:EXQ), a leading supplier of research products for qPCR analysis and biomarker development, today announced positive results in the company’s development of a diagnostic test for early detection of colorectal cancer in blood. The results were revealed during an oral presentation at the annual American Association for Cancer Research (AACR) meeting in Florida, USA, today.
